For the first time scientists have found an organism that can produce chlorophyll but does not engage in photosynthesis. The peculiar organism is dubbed ‘corallicolid’ because it is found in 70 per cent of corals around the world and may provide clues as to how to protect coral reefs in the future. “This is the second most abundant cohabitant of…
Read More
From ancient Mesopotamia to modern-day craft businesses, brewers have honed their skills in transforming wort — a sugary, steeped plant matter — into beer. All beers are made from grains, hops and yeast, and rely on a chemical process known as fermentation (which the yeast provides) to create an alcoholic beverage enjoyed throughout the world. Historically, brewers would take the sediment that collected at…
Read More
CDRD, Canada’s life sciences venture, TRIUMF, the country’s national particle accelerator centre, and TRIUMF Innovations, the centre’s commercialization arm have joined forces to advance and commercialize promising research in the field of novel radiopharmaceuticals. Speaking at the 11th International Symposium on Targeted Alpha Therapy (TAT 11) in Ottawa, the organizations announced today a new partnership that brings together their respective…
Read More
Aspect Biosystems, a Canadian biotech company pioneering microfluidic 3D bioprinting of human tissues, is pleased to announce a collaboration with the Center for Minimally Invasive Therapies (C-MIT) at the University of California, Los Angeles (UCLA). This collaboration includes the placement of an RX1™ Bioprinter at C-MIT to develop engineered tissues for regenerative medicine and organ-on-a-chip applications. Under the terms of the collaborative…
Read More
What happens inside the brain of an opera singer? Prof. Nancy Hermiston, Chair of the Voice Division and Director of the UBC Opera, has wondered about this for nearly 20 years. She suspects that opera training can rewire the brain, given how cognitively challenging it is as an art form. “Opera is very complicated,” Hermiston says. “Singers are required to…
Read More

Translating Research to Treat Prostate Cancer

A sun-lit Vancouver building houses a world-renowned team of scientists and researchers. They are oncologists, medical geneticists, biologists, biophysicists and computer scientists – at the leading edge of cancer research. And each day they come to work with the goal of combatting the most prevalent cancer among Canadian men. The Vancouver Prostate Centre (VPC) is a research hub hosted by UBC and…
Read More
If you, loved ones or friends suffer from diseases that may involve abnormal blood clotting, such as heart attack, stroke, atherosclerosis, deep vein thrombosis, pulmonary embolism or even cancer, commercials on “blood thinners” (anticoagulants) may catch your attention more than other drugs while watching your favorite TV show. Drug advertisements are everywhere! They often promise us clinical benefits that outweigh…
Read More
Tuberculosis (TB) is the world’s deadliest infectious killer but a team of SFU-led researchers is determined to fight it—using artificial intelligence. Just as the World Health Organization (WHO) observed World Tuberculosis Day on March 24, SFU computing science professors Leonid Chindelevitch and Maxwell Libbrecht partnered with University of Montreal researcher Jesse Shapiro for a new project. It uses machine learning to predict…
Read More
RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce the resumption of their First-in-Japan strategy. The Company, working with industry leaders, CJ PARTNERS, have initiated a program in Japan to realize its goal of launching its cell therapy products in Japan sooner than…
Read More
Today, the Government of Canada reaffirmed its longstanding support for TRIUMF with the announcement of a $292.7M investment over five years to support laboratory operations. This funding represents the largest single investment in TRIUMF to date. It comes in response to the bold vision presented in TRIUMF’s recently publishedFive-Year Plan 2020-2025. Details of the new funding were included in the 2019 federal budget, which was announced today in Ottawa.  TRIUMF is grateful for this strong support and appreciates the Government…
Read More